Please enable JavaScript to continue using this application.

Compare $ANIK vs $IMRX | Chartloom

Compare

$ANIK vs $IMRX

Anika Therapeutics Inc · Immuneering Corp

ANIK

Anika Therapeutics Inc

IMRX

Immuneering Corp

Compare $ANIK vs $IMRX

Comparing Anika Therapeutics Inc and Immuneering Corp

ANIKAnika Therapeutics Inc

IMRXImmuneering Corp

ANIKAnika Therapeutics Inc

Market cap

$262M

P/E (TTM)

—

Forward P/E (NTM)

57.30x

Forward P/S (NTM)

2.09x

Rev growth (TTM)

-2.5%

YTD performance

109.4%

52W performance

111.9%

FCF yield

0.2%

IMRXImmuneering Corp

Market cap

$255M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.5%

52W performance

-39.4%

FCF yield

-22.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIK

IMRX

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

IMRX

Immuneering Corp

Market Cap

ANIK$262M

IMRX$255M

Enterprise Value

ANIK$224M

IMRX$214M

Price

ANIK$19.58

IMRX$3.94

P/E Ratio

ANIKN/A

IMRXN/A

P/S Ratio

ANIK2.17x

IMRX526.64x

EV/Sales

ANIK1.85x

IMRX443.99x

EV/EBITDA

ANIK84.97x

IMRX0.00x

P/B Ratio

ANIK1.86x

IMRX1.38x

P/FCF Ratio

ANIK466.16x

IMRXN/A

EV/FCF

ANIK397.81x

IMRX-3.75x

PEG Ratio

ANIKN/A

IMRXN/A

Forward P/E (NTM)

ANIK57.30x

IMRXN/A

Forward P/S (NTM)

ANIK2.09x

IMRXN/A

Revenue (TTM)

ANIK$121M

IMRX$0

Revenue Growth (YoY)

ANIK-2.5%

IMRXN/A

Forward Rev Growth

ANIK5.2%

IMRX100.5%

Gross Margin (TTM)

ANIK62.2%

IMRX28.0%

Operating Margin (TTM)

ANIK0.0%

IMRX0.0%

EBITDA Margin (TTM)

ANIK2.2%

IMRX0.0%

Net Margin (TTM)

ANIK-3.1%

IMRX0.0%

FCF Margin (TTM)

ANIK0.5%

IMRXN/A

Net Income (TTM)

ANIK$-4M

IMRX$-57M

FCF (TTM)

ANIK$562K

IMRX$-57M

EPS (TTM)

ANIK-$0.28

IMRX-$0.89

ROE (TTM)

ANIK-270.0%

IMRX-2715.0%

ROA (TTM)

ANIK-204.0%

IMRX-2574.0%

ROIC (TTM)

ANIK-270.0%

IMRX-2715.0%

Cash

ANIK$38M

IMRX$41M

Debt

ANIK$0

IMRX$0

Net Cash/Debt

ANIK$38M

IMRX$41M

Current Ratio (TTM)

ANIK4.48x

IMRX19.47x

Quick Ratio (TTM)

ANIK3.05x

IMRX18.47x

Debt/Equity (TTM)

ANIK0.00x

IMRX0.00x

Debt/Assets (TTM)

ANIK0.0%

IMRX0.0%

Interest Coverage (TTM)

ANIKN/A

IMRXN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

IMRX0.00x

Beta

ANIK0.23

IMRX0.34

52W Performance

ANIK111.9%

IMRX-39.4%

YTD Performance

ANIK109.4%

IMRX-40.5%

% from 52W High

ANIK-14.4%

IMRX-53.5%

% from 52W Low

ANIK125.8%

IMRX9.4%

Asset Turnover (TTM)

ANIK0.65x

IMRX0.00x

FCF Yield (TTM)

ANIK0.2%

IMRX-22.4%

Earnings Yield (TTM)

ANIK-1.4%

IMRX-22.5%

Dividend Yield (TTM)

ANIKN/A

IMRXN/A

Rule of 40

ANIK-2.0

IMRX0.0

EV/GP/RG

ANIK0.81

IMRXN/A

Ticker research

View ANIK research View IMRX research

Metric	ANIK Anika Therapeutics Inc	IMRX Immuneering Corp
Market & Valuation
Market Cap	$262M	$255M
Enterprise Value	$224M	$214M
Price	$19.58	$3.94
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	526.64x
EV/Sales	1.85x	443.99x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	1.38x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	N/A
Revenue & Growth
Revenue (TTM)	$121M	$0
Revenue Growth (YoY)	-2.5%	N/A
Forward Rev Growth	5.2%	100.5%
Profitability
Gross Margin (TTM)	62.2%	28.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	0.0%
Net Margin (TTM)	-3.1%	0.0%
FCF Margin (TTM)	0.5%	N/A
Net Income (TTM)	$-4M	$-57M
FCF (TTM)	$562K	$-57M
EPS (TTM)	-$0.28	-$0.89
ROE (TTM)	-270.0%	-2715.0%
ROA (TTM)	-204.0%	-2574.0%
ROIC (TTM)	-270.0%	-2715.0%
Financial Health
Cash	$38M	$41M
Debt	$0	$0
Net Cash/Debt	$38M	$41M
Current Ratio (TTM)	4.48x	19.47x
Quick Ratio (TTM)	3.05x	18.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.34
52W Performance	111.9%	-39.4%
YTD Performance	109.4%	-40.5%
% from 52W High	-14.4%	-53.5%
% from 52W Low	125.8%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.00x
FCF Yield (TTM)	0.2%	-22.4%
Earnings Yield (TTM)	-1.4%	-22.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	0.0
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View IMRX research

Valuation

P/S Ratio

ANIK

2.17x

IMRX

526.64x

EV/FCF

IMRX

-3.75x

ANIK

397.81x

Growth & revenue

Revenue Growth TTM

ANIK

-2.5%

Forward Revenue Growth

IMRX

100.5%

ANIK

5.2%

Profitability & performance

Gross Margin

ANIK

62.2%

IMRX

28.0%

ROE

ANIK

-270.0%

IMRX

-2715.0%

FCF Yield %

ANIK

0.2%

IMRX

-22.4%

52-Week Performance

ANIK

111.9%

IMRX

-39.4%

Detailed metrics comparison

ANIK

Anika Therapeutics Inc

IMRX

Immuneering Corp

Market Cap

ANIK$262M

IMRX$255M

Enterprise Value

ANIK$224M

IMRX$214M

Price

ANIK$19.58

IMRX$3.94

P/E Ratio

ANIKN/A

IMRXN/A

P/S Ratio

ANIK2.17x

IMRX526.64x

EV/Sales

ANIK1.85x

IMRX443.99x

EV/EBITDA

ANIK84.97x

IMRX0.00x

P/B Ratio

ANIK1.86x

IMRX1.38x

P/FCF Ratio

ANIK466.16x

IMRXN/A

EV/FCF

ANIK397.81x

IMRX-3.75x

PEG Ratio

ANIKN/A

IMRXN/A

Forward P/E (NTM)

ANIK57.30x

IMRXN/A

Forward P/S (NTM)

ANIK2.09x

IMRXN/A

Revenue (TTM)

ANIK$121M

IMRX$0

Revenue Growth (YoY)

ANIK-2.5%

IMRXN/A

Forward Rev Growth

ANIK5.2%

IMRX100.5%

Gross Margin (TTM)

ANIK62.2%

IMRX28.0%

Operating Margin (TTM)

ANIK0.0%

IMRX0.0%

EBITDA Margin (TTM)

ANIK2.2%

IMRX0.0%

Net Margin (TTM)

ANIK-3.1%

IMRX0.0%

FCF Margin (TTM)

ANIK0.5%

IMRXN/A

Net Income (TTM)

ANIK$-4M

IMRX$-57M

FCF (TTM)

ANIK$562K

IMRX$-57M

EPS (TTM)

ANIK-$0.28

IMRX-$0.89

ROE (TTM)

ANIK-270.0%

IMRX-2715.0%

ROA (TTM)

ANIK-204.0%

IMRX-2574.0%

ROIC (TTM)

ANIK-270.0%

IMRX-2715.0%

Cash

ANIK$38M

IMRX$41M

Debt

ANIK$0

IMRX$0

Net Cash/Debt

ANIK$38M

IMRX$41M

Current Ratio (TTM)

ANIK4.48x

IMRX19.47x

Quick Ratio (TTM)

ANIK3.05x

IMRX18.47x

Debt/Equity (TTM)

ANIK0.00x

IMRX0.00x

Debt/Assets (TTM)

ANIK0.0%

IMRX0.0%

Interest Coverage (TTM)

ANIKN/A

IMRXN/A

Net Debt/EBITDA (TTM)

ANIK0.00x

IMRX0.00x

Beta

ANIK0.23

IMRX0.34

52W Performance

ANIK111.9%

IMRX-39.4%

YTD Performance

ANIK109.4%

IMRX-40.5%

% from 52W High

ANIK-14.4%

IMRX-53.5%

% from 52W Low

ANIK125.8%

IMRX9.4%

Asset Turnover (TTM)

ANIK0.65x

IMRX0.00x

FCF Yield (TTM)

ANIK0.2%

IMRX-22.4%

Earnings Yield (TTM)

ANIK-1.4%

IMRX-22.5%

Dividend Yield (TTM)

ANIKN/A

IMRXN/A

Rule of 40

ANIK-2.0

IMRX0.0

EV/GP/RG

ANIK0.81

IMRXN/A

Ticker research

View ANIK research View IMRX research

Metric	ANIK Anika Therapeutics Inc	IMRX Immuneering Corp
Market & Valuation
Market Cap	$262M	$255M
Enterprise Value	$224M	$214M
Price	$19.58	$3.94
P/E Ratio	N/A	N/A
P/S Ratio	2.17x	526.64x
EV/Sales	1.85x	443.99x
EV/EBITDA	84.97x	0.00x
P/B Ratio	1.86x	1.38x
P/FCF Ratio	466.16x	N/A
EV/FCF	397.81x	-3.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	57.30x	N/A
Forward P/S (NTM)	2.09x	N/A
Revenue & Growth
Revenue (TTM)	$121M	$0
Revenue Growth (YoY)	-2.5%	N/A
Forward Rev Growth	5.2%	100.5%
Profitability
Gross Margin (TTM)	62.2%	28.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	2.2%	0.0%
Net Margin (TTM)	-3.1%	0.0%
FCF Margin (TTM)	0.5%	N/A
Net Income (TTM)	$-4M	$-57M
FCF (TTM)	$562K	$-57M
EPS (TTM)	-$0.28	-$0.89
ROE (TTM)	-270.0%	-2715.0%
ROA (TTM)	-204.0%	-2574.0%
ROIC (TTM)	-270.0%	-2715.0%
Financial Health
Cash	$38M	$41M
Debt	$0	$0
Net Cash/Debt	$38M	$41M
Current Ratio (TTM)	4.48x	19.47x
Quick Ratio (TTM)	3.05x	18.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.34
52W Performance	111.9%	-39.4%
YTD Performance	109.4%	-40.5%
% from 52W High	-14.4%	-53.5%
% from 52W Low	125.8%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.00x
FCF Yield (TTM)	0.2%	-22.4%
Earnings Yield (TTM)	-1.4%	-22.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2.0	0.0
EV/GP/RG	0.81	N/A
Ticker research	View ANIK research	View IMRX research